Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 10Thoracic 5Head & Neck 3Breast 3Plasma cell 2Other solid neoplasm 2Lymphoid 2Gynecologic 2CNS 2Tumor-Agnostic 1Other hematologic neoplasm 1NET 1Genitourinary 1Endocrine 1

Conditions

Pseudomyxoma Peritonei 1Mesothelioma, Malignant 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1Advanced Cancer 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Referral and Consultation × Other solid neoplasm × Clear all
NCT03181854 2019-08-06

Randomized Controlled Trial of Integrated Early Palliative Care

Seoul National University Hospital

Phase NA Completed
144 enrolled
Other solid neoplasm

Advanced Cancer

NCT01126346 2018-07-03

HOPE

Wake Forest University Health Sciences

Phase NA Completed
10 enrolled
GastrointestinalGynecologicOther solid neoplasmThoracic

Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Appendiceal Neoplasms, Colonic Neoplasms, Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡